Company: HCTI
Filing Date: 2025-03-07
Form Type: DEF 14A
Source: 0001213900-25-021346
Chunk: 8

Company: Healthcare Triangle, Inc.
Filing Date: 2025-03-07
Form: DEF 14A
Chunk 8
---
hakevilayil is qualified to serve as a member of our Board based on his outstanding skills and unique experience in IT industry in connection with healthcare domain. Ronald McClurg.Mr. McClurg has over 30 years of financial leadership experience with public and private companies. Mr. McClurg has served as Chief Financial Officer of NeuroOne Medical Technologies Corp. (Nasdaq: NMTC) since January 2021. Prior to joining NeuroOne, from October 2003 to June 2019, Mr. McClurg served as VP — Finance and Administration and Chief Financial Officer of Incisive Surgical, Inc., a privately -heldmedical device manufacturer. Prior to 2003, Mr. McClurg served as Chief Financial Officer and Treasurer of Wavecrest Corporation, a privately -heldmanufacturer of electronic test instruments for the semiconductor industry, and served as Chief Financial Officer for several publicly -heldcompanies, including Video Sentry Corporation, Insignia Systems, Inc. (Nasdaq: ISIG), and Orthomet, Inc. Currently, he serves on the board of governors of Biomagnetic Sciences, LLC and serves as a director and audit committee chair for Biotricity, Inc. (Nasdaq: BTCY). Mr. McClurg holds a Bachelor of Business Administration degree in accounting from the University of Wisconsin — Eau Claire.We believe that Mr. Ronald McClurg is qualified to serve as a member of our Board based on his outstanding skills and unique experience in Finance domain with public companies. Jainal Bhuiyan.Mr. Jainal is currently a Senior Managing Director in investment banking at Paulson Investment Company. Prior to Paulson he was a partner at HRA Capital, a boutique investment bank he co -foundedin 2012. Over the course of his 18 years of healthcare investment banking and capital markets experience, he has advised private and public healthcare companies from start -upsto commercially mature enterprises, totaling more than $3B in transactions. He holds FINRA Series 7, Series 63 and Series 79 licenses. We believe that Mr. Jainal Bhuiyan is qualified to serve as a member of our Board based on his outstanding skills and unique experience in investment banking in healthcare sector. Recommendation of the Board of Directors THE BOARD RECOMMENDS THAT YOU VOTE “FOR” THE ELECTION OF THE NOMINEES. 6 CORPORATE GOVERNANCE Meetings of the Board of Directors Our Board of Directors held 4 regular meetings in 2024 and acted by written consent 3